减压补充品市场规模 - 按原料、型态、类别和分销管道 - 区域展望、竞争策略和细分市场预测（~2033 年）

预计到2033年，全球减压补充品市场规模将成长至10168.8亿，复合年增长率为7.04%。

为缓解压力而开发的锭剂旨在帮助人们控制和减轻压力对其思想和情绪的影响。这些补充品通常由具有放鬆效果的天然成分组合而成。洋甘菊和缬草根等草本萃取物因其对神经系统的镇静作用而闻名。此外，海带含有红景天和睡茄等适应原，有助于身体适应压力源。

围绕 COVID-19 爆发和结束的不确定性引发了许多问题。除了其他心理健康问题外，压力、焦虑、悲伤、愤怒和怨恨也变得越来越普遍。这场流行病扰乱了社会连结、工作和收入，导致世界各地的压力水平不断上升，焦虑和绝望感急剧增加。随着心理健康问题的增加，越来越多的人正在寻求可行的缓解压力的方法，例如补充品。

本报告调查了全球减压补充品市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争格局以及主要企业。

目录

第一章简介

第二章调查方法

第三章执行摘要

第四章市场动态

• 驱动因素、限制因素、机会与挑战分析
• COVID-19 对市场的影响

第五章 市场变数与展望

• SWOT分析
• PESTEL分析
• 波特五力分析
• 热图分析

第六章 竞争状况

• 製造地、销售区域、产品类型分布
• 併购、联盟、产品发布、合作

第七章全球减压补充品市场：按类型

• 全球市占率及预测
• 睡茄
• 洋甘菊
• 熏衣草
• 褪黑素
• 红景天
• L-茶氨酸
• 其他的

第八章全球减压补充品市场：型态

• 全球市占率及预测
• 胶囊/片剂
• 油
• 粉末
• 其他的

第九章全球减压补充品市场：按类别

• 全球市占率及预测
• 有机产品
• 常规产品

第十章全球减压补充品市场：按分销管道

• 全球市占率及预测
• 大卖场/超级市场
• 便利商店
• 药局/药房
• 专卖店
• 线上管道
• 其他的

第十一章全球减压补充品市场预测

• 市场规模/市场占有率

第十二章全球减压补充品市场：依成分分类

• 市场规模/市场占有率趋势/预测

第十三章全球减压补充品市场：型态

• 市场规模/市场占有率趋势/预测

第十四章全球减压补充品市场：依类别

• 市场规模/市场占有率趋势/预测

第十五章全球减压补充品市场：按分销管道

• 市场规模/市场占有率趋势/预测

第十六章全球减压补充品市场：按地区

• 市场规模/市场占有率趋势/预测
• 亚太地区
• 欧洲
• 中东/非洲
• 北美洲
• 拉丁美洲

第十七章 公司简介

• Himalaya Drug Company
• Cureveda
• Natureplus
• Panchamrit
• Nutraceutical International Company
• Pharmalinea Ltd.
• Virtue Vitamins LIC
• Foresta Organics
• Ricola
• ADM
• 其他的

第十八章简称

第十九章 参考链接

第20章 结论

第二十一章 研究范围

Stress Relief Supplement Market Introduction and Overview

According to SPER market research, 'Stress Relief Supplement Market Size- By Source, By Form, By Category, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Stress Relief Supplement Market is predicted to reach 1016.88 Million by 2033 with a CAGR of 7.04%.

Tablets developed to alleviate stress are intended to assist people control and mitigate the effects of stress on their thoughts and emotions. These supplements are often made from a combination of natural ingredients that have relaxing properties. Herbal extracts, such as chamomile and valerian root, are known to have calming benefits on the nervous system. Additionally, comves contain adaptogens, including rhodiola and ashwagandha, which help the body adjust to stressors.

Numerous more widespread issues have emerged as a result of the COVID-19 epidemic and the uncertainty surrounding the crisis's conclusion. Together with other mental health conditions, stress, anxiety, sadness, rage, and anger are growing more prevalent. The pandemic raised stress levels worldwide as a result of disruptions to social ties, employment, and income, which sharply raised the incidence of anxiety and despair. A growing number of people are searching for doable stress-reduction techniques, like supplementation, as mental health problems increase.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Source, By Form, By Category, By Distribution Channel

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Himalaya Drug Company, Cureveda, Natureplus, Panchamrit, Nutraceutical International Company, Pharmalinea Ltd, Virtue Vitamins LIC, Foresta Organics, Ricola, ADM.

Global Stress Relief Supplement Market Segmentation:

By Source: Based on the Source, Global Stress Relief Supplement Market is segmented as; Ashwagandha, Chamomile, Lavender, Melatonin, Rhodiola, L-theanine, Others.

By Form: Based on the Form, Global Stress Relief Supplement Market is segmented as; Capsules & Tablets, Oils, Powder, Others.

By Category: Based on the Category, Global Stress Relief Supplement Market is segmented as; Organic, Conventional.

By Distribution Channel: Based on the Distribution Channel, Global Stress Relief Supplement Market is segmented as; Hypermarket/Supermarket, Convenience Stores, Drug Stores/Pharmacies, Speciality Stores, Online Channels, Others.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Stress Relief Supplement Market

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Stress Relief Supplement Market Manufacturing Base Distribution, Sales Area, Ingredients
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Stress Relief Supplement Market

7. Global Stress Relief Supplement Market, By Source (USD Million)

• 7.1. Global Stress Relief Supplement Market Value Share and Forecast, By Source 2024-2033
• 7.2. Ashwagandha
• 7.3. Chamomile
• 7.4. Lavender
• 7.5. Melatonin
• 7.6. Rhodiola
• 7.7. L-theanine
• 7.8. Others

8. Global Stress Relief Supplement Market, By Form (USD Million)

• 8.1. Global Stress Relief Supplement Market Value Share and Forecast, By Form 2024-2033
• 8.2. Capsules & Tablets
• 8.3. Oils
• 8.4. Powder
• 8.5. Others

9. Global Stress Relief Supplement Market, By Category (USD Million)

• 9.1. Global Stress Relief Supplement Market Size Value Share and Forecast, By Category 2024-2033
• 9.2. Organic
• 9.3. Conventional

10. Global Stress Relief Supplement Market, By Distribution Channel (USD Million)

• 10.1. Global Stress Relief Supplement Market Size Value Share and Forecast, By Distribution Channel 2024-2033
• 10.2. Hypermarket/Supermarket
• 10.3. Convenience Stores
• 10.4. Drug Stores/Pharmacies
• 10.5. Specialty Stores
• 10.6. Online Channels
• 10.7. Others

11. Global Stress Relief Supplement Market, Forecast, 2020-2033 (USD Million)

• 11.1. Global Stress Relief Supplement Market Size and Market Share

12. Global Stress Relief Supplement Market, By Source 2020-2033 (USD Million)

• 12.1. Global Stress Relief Supplement Market Size and Market Share, By Source (2020-2026)
• 12.2. Global Stress Relief Supplement Market Size and Market Share, By Source (2027-2033)

13. Global Stress Relief Supplement Market, By Form 2020-2033 (USD Million)

• 13.1. Global Stress Relief Supplement Market Size and Market Share, By Form (2020-2026)
• 13.2. Global Stress Relief Supplement Market Size and Market Share, By Form (2027-2033)

14. Global Stress Relief Supplement Market, By Category 2020-2033 (USD Million)

• 14.1. Global Stress Relief Supplement Market Size and Market Share, By Category (2020-2026)
• 14.2. Global Stress Relief Supplement Market Size and Market Share, By Category (2027-2033)

15. Global Stress Relief Supplement Market, By Distribution Channel 2020-2033 (USD Million)

• 15.1. Global Stress Relief Supplement Market Size and Market Share, By Distribution Channel (2020-2026)
• 15.2. Global Stress Relief Supplement Market Size and Market Share, By Distribution Channel (2027-2033)

16. Global Stress Relief Supplement Market, By Region, 2020-2033 (USD Million)

• 16.1. Global Stress Relief Supplement Market Size and Market Share, By Region (2020-2026)
• 16.2. Global Stress Relief Supplement Market Size and Market Share, By Region (2027-2033)
• 16.3. Asia-Pacific
  • 16.3.1. Australia
  • 16.3.2. China
  • 16.3.3. India
  • 16.3.4. Japan
  • 16.3.5. South Korea
  • 16.3.6. Rest of Asia-Pacific
• 16.4. Europe
  • 16.4.1. France
  • 16.4.2. Germany
  • 16.4.3. Italy
  • 16.4.4. Spain
  • 16.4.5. United Kingdom
  • 16.4.6. Rest of Europe
• 16.5. Middle East and Africa
  • 16.5.1. Kingdom of Saudi Arabia
  • 16.5.2. United Arab Emirates
  • 16.5.3. Rest of Middle East & Africa
• 16.6. North America
  • 16.6.1. Canada
  • 16.6.2. Mexico
  • 16.6.3. United States
• 16.7. Latin America
  • 16.7.1. Argentina
  • 16.7.2. Brazil
  • 16.7.3. Rest of Latin America

17. Company Profile

• 17.1. Himalaya Drug Company
  • 17.1.1. Company details
  • 17.1.2. Financial outlook
  • 17.1.3. Product summary
  • 17.1.4. Recent developments
• 17.2. Cureveda
  • 17.2.1. Company details
  • 17.2.2. Financial outlook
  • 17.2.3. Product summary
  • 17.2.4. Recent developments
• 17.3. Natureplus
  • 17.3.1. Company details
  • 17.3.2. Financial outlook
  • 17.3.3. Product summary
  • 17.3.4. Recent developments
• 17.4. Panchamrit
  • 17.4.1. Company details
  • 17.4.2. Financial outlook
  • 17.4.3. Product summary
  • 17.4.4. Recent developments
• 17.5. Nutraceutical International Company
  • 17.5.1. Company details
  • 17.5.2. Financial outlook
  • 17.5.3. Product summary
  • 17.5.4. Recent developments
• 17.6. Pharmalinea Ltd.
  • 17.6.1. Company details
  • 17.6.2. Financial outlook
  • 17.6.3. Product summary
  • 17.6.4. Recent developments
• 17.7. Virtue Vitamins LIC
  • 17.7.1. Company details
  • 17.7.2. Financial outlook
  • 17.7.3. Product summary
  • 17.7.4. Recent developments
• 17.8. Foresta Organics
  • 17.8.1. Company details
  • 17.8.2. Financial outlook
  • 17.8.3. Product summary
  • 17.8.4. Recent developments
• 17.9. Ricola
  • 17.9.1. Company details
  • 17.9.2. Financial outlook
  • 17.9.3. Product summary
  • 17.9.4. Recent developments
• 17.10. ADM
  • 17.10.1. Company details
  • 17.10.2. Financial outlook
  • 17.10.3. Product summary
  • 17.10.4. Recent developments
• 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope